000			02289 a2200589 4500
005			20250516205142.0
264		0	_c20140725
008			201407s 0 0 eng d
022			_a1524-4563
024	7		_a10.1161/HYPERTENSIONAHA.113.03025 _2doi
040			_aNLM _beng _cNLM
100	1		_aFu, Zhuo
245	0	0	_aAngiotensin-(1-7) recruits muscle microvasculature and enhances insulin's metabolic action via mas receptor. _h[electronic resource]
260			_bHypertension (Dallas, Tex. : 1979) _cJun 2014
300			_a1219-27 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAngiotensin I _xadministration & dosage
650	0	4	_aAngiotensin II _xadministration & dosage
650	0	4	_aAnimals
650	0	4	_aArteries _xdrug effects
650	0	4	_aBlood Flow Velocity _xdrug effects
650	0	4	_aBlotting, Western
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEndothelium, Vascular _xphysiology
650	0	4	_aExtracellular Signal-Regulated MAP Kinases _xmetabolism
650	0	4	_aGlucose _xmetabolism
650	0	4	_aHindlimb _xblood supply
650	0	4	_aHypoglycemic Agents _xadministration & dosage
650	0	4	_aIn Vitro Techniques
650	0	4	_aInfusions, Intravenous
650	0	4	_aInsulin _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMicrovessels _xdrug effects
650	0	4	_aMuscle, Skeletal _xblood supply
650	0	4	_aPeptide Fragments _xadministration & dosage
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aProto-Oncogene Mas
650	0	4	_aProto-Oncogene Proteins _xantagonists & inhibitors
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReceptors, G-Protein-Coupled _xantagonists & inhibitors
650	0	4	_aRegional Blood Flow _xdrug effects
650	0	4	_aVasodilation _xdrug effects
700	1		_aZhao, Lina
700	1		_aAylor, Kevin W
700	1		_aCarey, Robert M
700	1		_aBarrett, Eugene J
700	1		_aLiu, Zhenqi
773	0		_tHypertension (Dallas, Tex. : 1979) _gvol. 63 _gno. 6 _gp. 1219-27
856	4	0	_uhttps://doi.org/10.1161/HYPERTENSIONAHA.113.03025 _zAvailable from publisher's website
999			_c23717356 _d23717356